Please be aware that this website relies on the use of cookies to function correctly and involves some cookies being downloaded onto your device. This helps us to improve the content of the website so that it is more useful and relevant to you.
Allow cookiesPrivacy and Cookies Policy
banner image

Elanco Coronavirus statement (COVID-19) April 2020

Elanco is closely monitoring the situation on the spread of Coronavirus (COVID-19) from both a local and global perspective. Our primary focus is to our teams, our supply to our customers and keeping you informed. We have had questions about supply of product. Elanco benefits from a global manufacturing and supply network to source its ingredients and medicines plus there are managed stocks of medicines held in the UK and in other distribution hubs. In terms of supply of products or ingredients supplied from China, Elanco has not experienced any difficulties with supply or manufacture of any products from China to date.

Locally we are taking all actions to ensure we comply with official guidance and instructions. With the recent request to avoid all non-essential contact, we have moved all of our team to remote-working until further notice to minimise spread of the virus, protect our teams and our customers.

Elanco will update this information as needed as we continue to monitor the situation and we wish to reassure customers that there is currently not any impact of coronavirus on supply of Elanco products to the United Kingdom and Ireland.

See further details on the global Elanco.com website.